Volume 8, Issue 3, September 2014, Pages 1252–1257
Imane ES-SAID1, Hicham ELFAZAZI2, and Mimoun Zouhdi3
1 Department of Microbiology, Faculty of Medicine and Pharmacy, Mohammed V-Souissi, Rabat, Morocco
2 Department of Gynecology Obstetrics, Mohammed V Military Hospital, Rabat, Morocco
3 Microbiology Laboratory, Ibn Sina Hospital, Rabat, Morocco
Original language: English
Copyright © 2014 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: Acinetobacter baumannii (A. baumannii) is one of the most important nosocomial pathogens, Increasing resistance coupled with the fact that few novel antibiotics are currently available or in the pipeline, leaves patients and physicians with a very limited armamentarium against these pathogens. Combination therapies are considered as effective options to overcome this matter. Materials and methods: Fifty A. baumannii isolates were collected from clinical specimens, from patients in ICU at Ibn Sina Hospital in Rabat, Morocco during the January 2011
Author Keywords: Imipenem, colistin, rifampicin, combination, Acinetobacter baumannii.
Imane ES-SAID1, Hicham ELFAZAZI2, and Mimoun Zouhdi3
1 Department of Microbiology, Faculty of Medicine and Pharmacy, Mohammed V-Souissi, Rabat, Morocco
2 Department of Gynecology Obstetrics, Mohammed V Military Hospital, Rabat, Morocco
3 Microbiology Laboratory, Ibn Sina Hospital, Rabat, Morocco
Original language: English
Copyright © 2014 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: Acinetobacter baumannii (A. baumannii) is one of the most important nosocomial pathogens, Increasing resistance coupled with the fact that few novel antibiotics are currently available or in the pipeline, leaves patients and physicians with a very limited armamentarium against these pathogens. Combination therapies are considered as effective options to overcome this matter. Materials and methods: Fifty A. baumannii isolates were collected from clinical specimens, from patients in ICU at Ibn Sina Hospital in Rabat, Morocco during the January 2011
Author Keywords: Imipenem, colistin, rifampicin, combination, Acinetobacter baumannii.
How to Cite this Article
Imane ES-SAID, Hicham ELFAZAZI, and Mimoun Zouhdi, “In vitro activity of imipenem combination with colistin or rifampicin against clinical isolates of Acinetobacter baumannii and his antimicrobial susceptibility profil,” International Journal of Innovation and Applied Studies, vol. 8, no. 3, pp. 1252–1257, September 2014.
